Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Functional neurological disorders in hospitalized children and adolescents: a retrospective cohort study.

Acta neurologica Belgica·2026
Same author

Carrying the weight in silence: lived realities of epilepsy caregivers in Shai Osudoku and Ningo Prampram.

Epilepsy & behavior : E&B·2026
Same author

Neurophysiological characterization and targeted treatment of rhythmic cortical myoclonus in an SCN8A gain-of-function variant.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Video-EEG polygraphy in the clinical characterization of hyperkinetic movement disorders: a tertiary referral cohort.

Frontiers in neurology·2026
Same author

Reliability of TRUST ASL for measuring cerebral blood flow and blood-brain barrier water exchange: a scan-rescan pilot study in healthy subjects and patients with epilepsy.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jun 2, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Immune-mediated epilepsies.

Tiziana Granata1, Helen Cross, William Theodore

  • 1Department of Child Neurology, Carlo Besta Neurological Institute, Milan, Italy. granata@istituto-besta.it

Epilepsia
|May 6, 2011
PubMed
Summary
This summary is machine-generated.

Immunity, including adaptive immune responses, plays a pathogenic role in several types of epilepsy. Research is exploring immune mechanisms and therapeutic targets for immune-mediated epilepsies.

More Related Videos

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Area of Science:

  • Neuroimmunology
  • Epileptology
  • Immunology

Background:

  • Immune system involvement in epilepsy is suggested by treatment efficacy and inflammation markers.
  • Both innate and adaptive immunity may contribute to seizures and epileptogenesis.
  • Adaptive immunity involves antigen-specific lymphocytes and antibodies, implicated in infections and autoimmune disorders.

Purpose of the Study:

  • To critically review evidence for pathogenic roles of adaptive immunity in epilepsy.
  • To discuss potential mechanisms and therapeutic targets in immune-mediated epilepsies.
  • To highlight future research directions for diagnosis and treatment.

Main Methods:

  • Literature review of clinical and experimental data.
  • Analysis of immune responses in various epileptic disorders.
  • Discussion of immunological mechanisms and therapeutic strategies.

Main Results:

  • Adaptive immune responses are implicated in the pathogenesis of specific epilepsy types.
  • Inflammation markers and autoantibodies are found in individuals with epileptic disorders.
  • Innate immunity also contributes through inflammatory mediators and resident brain immune cells.

Conclusions:

  • Adaptive immunity is a significant factor in certain epilepsies.
  • Understanding immune mechanisms is crucial for developing targeted therapies.
  • Further research is needed to improve diagnosis and treatment of immune-mediated epilepsies.